- Perioral Dermatitis Successfully Treated with Topical Ivermectin
-
Charnowski S, Wollenberg A, Reinholz M
- KMID: 2456668
- Ann Dermatol.
- 2019 Aug;31(Suppl):S27-S28.
- doi: 10.5021/ad.2019.31.S.S27
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Perioral Dermatitis Successfully Treated with Topical Ivermectin
-
Charnowski S, Wollenberg A, Reinholz M
- KMID: 2456641
- Ann Dermatol.
- 2019 Aug;31(Suppl 1):S27-S28.
- doi: 10.5021/ad.2019.31.S.S27
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Successful Treatment of Genital Warts with Ingenol Mebutate Monitored with Optical Coherence Tomography and Reflectance Confocal Microscopy
-
Reinholz M, Clanner-Engelshofen BM, Heppt MV, Hirai Y, Ruzicka T, Berking C, von Braunmühl T
- KMID: 2451481
- Ann Dermatol.
- 2019 Aug;31(4):434-437.
- doi: 10.5021/ad.2019.31.4.434
Ingenol mebutate (IM) is approved for the treatment of actinic keratosis and induces cell death in precancerous lesions. The efficacy of IM in the treatment of genital warts was investigated... -
- CITED
-
- Close
- SHARE
-
- Close
- Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease
-
Reinholz M, Ruzicka T, Schauber J
- KMID: 2434676
- Ann Dermatol.
- 2012 May;24(2):126-135.
Chronic inflammatory skin diseases such as atopic dermatitis, psoriasis or rosacea are very common. Although their exact pathogenesis is not completely understood all three diseases are characterized by dysregulation of... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety Results of a Drug-Free Cosmetic Fluid for Perioral Dermatitis: The Toleriane Fluide Efficacy in Perioral Dermatitis (TOLPOD) Study
-
Ehmann L, Reinholz M, Maier T, Lang M, Wollenberg A
- KMID: 2265586
- Ann Dermatol.
- 2014 Aug;26(4):462-468.
- doi: 10.5021/ad.2014.26.4.462
BACKGROUND: Perioral dermatitis (POD) is a common inflammatory skin disease without standard therapy. OBJECTIVE: We sought to evaluate the clinical value of a soothing fluid for the treatment of POD. METHODS: We... -
- CITED
-
- Close
- SHARE
-
- Close
